VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_12-vv-00378
Package ID: USCOURTS-cofc-1_12-vv-00378
Petitioner: George Dominguez
Filed: 2012-06-14
Decided: 2018-05-02
Vaccine: tetanus-diphtheria-acellular pertussis
Vaccination date: 2011-08-31
Condition: Wegener’s granulomatosis
Outcome: denied
Award amount USD: 

AI-assisted case summary:
George Dominguez filed a petition on June 14, 2012, alleging that a tetanus-diphtheria-acellular pertussis (TDaP) vaccination he received on August 31, 2011 caused him to develop Wegener's granulomatosis, or alternatively, significantly aggravated his condition.

This was a contested case. Respondent filed a Rule 4 report in May 2013 concluding that compensation was not appropriate, citing the absence of a medical theory connecting the TDaP vaccine to Wegener's granulomatosis and the lack of any treating physician endorsing such a connection. Petitioner's initial counsel withdrew in January 2015; current counsel entered an appearance in March 2015. Petitioner submitted expert reports co-authored by Dr. Judy A. Mikovits and Dr. Francis W. Ruscetti, theorizing that the vaccine triggered a cytokine and chemokine storm leading to Wegener's granulomatosis. Respondent's expert, Dr. Thomas Forsthuber, responded that the cited articles did not support the theory and that the causes of Wegener's granulomatosis are unknown.

In March 2018, after Special Master Moran identified weak aspects of petitioner's case and the disparity in credentials between the parties' experts, petitioner moved for a decision dismissing his own petition, acknowledging he was unable to prove entitlement to compensation and that dismissal would end all of his rights in the Vaccine Program. Special Master Moran denied compensation on April 2, 2018, finding that the medical records did not support a Table injury and that the medical opinion offered on petitioner's behalf was not persuasive.

Separately, Special Master Moran had awarded $75,011.50 in interim attorneys' fees and costs; Judge Kaplan of the Court of Federal Claims remanded that award in March 2018, finding the special master had abused his discretion by failing to conduct an independent review of whether the fees were reasonable before making the award.

Theory of causation field:
TDaP Aug 31, 2011 → Wegener's granulomatosis (or significant aggravation). Contested. Experts: Mikovits + Ruscetti (petitioner); Forsthuber (respondent). Petitioner moved to dismiss Mar 30, 2018; SM Moran DENIED Apr 2, 2018. Interim fees $75,011.50 remanded by CFC (Judge Kaplan) for reasonableness review. Counsel: Clifford Shoemaker, Shoemaker Gentry & Knickelbein, Vienna VA. All DB fields correct.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_12-vv-00378-1
Date issued/filed: 2018-03-23
Pages: 9
Docket text: PUBLIC DECISION Judge Vaccine Reported Opinion (Originally filed: 03/08/2018) regarding 145 Motion for Review; 153 Order on Motion for Review. Signed by Judge Elaine D. Kaplan. (bh) Service on parties made.
--------------------------------------------------------------------------------
Case 1:12-vv-00378-EDK Document 159 Filed 03/23/18 Page 1 of 9
In the United States Court of Federal Claims
No. 12-378V
(Filed Under Seal: March 8, 2018 | Reissued for Publication: March 23, 2018)*
) Keywords: Vaccine Act; Interim
GEORGE DOMINGUEZ, ) Attorneys’ Fees; Reasonable Attorneys’
) Fees; Lodestar; Abuse of Discretion.
Petitioner, )
)
v. )
)
SECRETARY OF HEALTH AND HUMAN )
SERVICES, )
)
Respondent. )
)
Clifford J. Shoemaker, Shoemaker, Gentry & Knickelbein, Vienna, VA, for Petitioner.
Darryl R. Wishard, Senior Trial Attorney, Torts Branch, Civil Division, U.S. Department of
Justice, Washington, DC, for Respondent, with whom were Heather L. Pearlman, Assistant
Director, Catharine E. Reeves, Deputy Director, C. Salvatore D’Alessio, Acting Director, and
Chad A. Readler, Acting Assistant Attorney General.
OPINION AND ORDER
KAPLAN, Judge.
Currently before the Court is a motion for review of an attorney fee award Special Master
Christian Moran issued pursuant to the National Childhood Vaccine Injury Act of 1986, 42
U.S.C. §§ 300aa-1 to -34 (hereinafter the Vaccine Act). Special Master Moran awarded the
petitioner the full amount of the interim attorneys’ fees and costs he requested without
conducting a review of whether either the hours counsel billed or the rate he claimed were
reasonable. He awarded the full amount because the Secretary of Health and Human Services
(the Secretary) had declined to pose any specific objections to the items in the fee application,
but instead deferred to the special master to exercise his discretion to determine a reasonable fee
award.
The Secretary seeks review of the special master’s fee award, contending, among other
things, that—regardless of whether the government files specific objections to a request for
* Pursuant to Vaccine Rule 18(b), this opinion was initially filed on March 8, 2018, and the
parties were afforded fourteen days to propose redactions. The parties did not propose any
redactions and, accordingly, this opinion is reissued in its original form for publication.

Case 1:12-vv-00378-EDK Document 159 Filed 03/23/18 Page 2 of 9
attorneys’ fees and costs—the Special Master has a statutory obligation to determine whether the
fees requested are reasonable before making an award under the Vaccine Act. Petitioner has filed
a response to the motion for review in which he contends that the special master properly
exercised his discretion in awarding interim attorneys’ fees and costs.
As discussed below, the Court concludes that the special master abused his discretion by
failing to conduct an independent review and make a determination of whether the fee award he
issued met the statutory reasonableness requirement. Accordingly, the Court GRANTS the
government’s motion for review, sets aside the special master’s decision, and REMANDS the
matter to the special master for further proceedings.
BACKGROUND
On June 14, 2012, Mr. Dominguez filed a petition for compensation under the Vaccine
Act. ECF No. 1. In that petition, Mr. Dominguez alleges that on August 31, 2011, he received a
tetanus-diphtheria-pertussis vaccine that caused him to develop Wegener’s Granulomatosis. Pet.
¶¶ 1, 7–8. The parties have since been engaged in proceedings before Special Master Moran, and
a hearing on Mr. Dominguez’s entitlement to compensation is scheduled for April 5, 2018. See
ECF No. 126.
In the meantime, on July 29, 2017, Mr. Dominguez filed an application seeking an award
of $40,915.80 in interim attorneys’ fees and $34,095.70 in costs, for a total award of $75,011.50.
ECF No. 124. The Secretary filed his response to Petitioner’s fee application on July 31, 2017.
ECF No. 125.
In his response, the Secretary acknowledged that Petitioner had satisfied the legal
prerequisites to an award of interim fees. He declined to take a position, however, as to whether
the Special Master should issue such an award or as to the reasonableness of the amount of fees
and costs Petitioner requested. Instead, he stated that “[s]hould the Special Master conclude that
an interim award of attorneys’ fees and costs is appropriate, respondent respectfully recommends
that the Special Master exercise discretion and determine a reasonable award.” Resp’t’s Resp. to
Pet’r’s Appl. for Interim Att’ys’ Fees & Costs at 3 (footnote omitted).
The Secretary explained that “[n]either the Vaccine Act nor Vaccine Rule 131
contemplates any role for respondent in the resolution of a request by a petitioner for an award of
attorneys’ fees and costs.” Id. at 1. And although in previous cases the Secretary had provided
“detailed objections to requests for attorneys’ fees and costs . . . as a courtesy to the Court,” the
Secretary noted that he “no longer ha[d] sufficient resources” to do so. Id. at 3 n.3. “In addition,”
the Secretary observed, in his experience “providing detailed objections only leads to ‘a second
major litigation’ over fees, as cautioned against by the Supreme Court in Fox [v. Vice, 563 U.S.
826 (2011)], as well as supplemental fee requests that are routinely granted by the Court (i.e.,
1 Vaccine Rule 13 states that a request for attorneys’ fees and costs “must be filed no later than
180 days after the entry of judgment or the filing of an order concluding proceedings,” and
instructs that “the clerk will forward the fee request to the special master for a decision thereon.”
2

Case 1:12-vv-00378-EDK Document 159 Filed 03/23/18 Page 3 of 9
‘fees for fees’), which negate any purpose of the objections asserted by respondent.” Id.
(emphasis omitted).
On December 18, 2017, Special Master Moran issued a decision on the interim fee
application. ECF No. 138. He concluded that Mr. Dominguez was eligible for an award of fees
because he had filed his petition in good faith and had a reasonable basis for doing so. Id. at 2.
The special master also found that “an interim award [wa]s warranted . . . to alleviate an undue
hardship and costly experts.” Id. at 3.
With respect to the amount of the award, the special master granted the application in full
without determining whether the hours or rate claimed were reasonable within the meaning of
the applicable case law. Relying instead upon his decision the preceding month in Swintosky v.
Secretary of Health and Human Services, No. 12-403V, 2017 WL 5899239 (Fed. Cl. Office of
the Special Masters Nov. 6, 2017), the special master ruled that the fee request should be granted
in full because by declining to take a position and instead deferring to the special master’s
discretion, the Secretary had “waived any objections to the amount of fees requested.” Id.
(footnote omitted).
The Secretary then filed a motion for review in this Court on January 16, 2018. ECF No.
145. In the motion, he contends that the special master “abused his discretion when he failed to
make a finding regarding the reasonableness of petitioner’s application for attorneys’ fees and
costs” and instead awarded Mr. Dominguez the full amount he requested “on the sole asserted
basis that respondent ‘has waived any objections to the amount of fees requested.’” Id. at 1. The
Secretary requests that the Court reverse the special master’s decision and remand the matter
back to him “for an appropriate determination regarding the reasonableness of petitioner’s
application for attorneys’ fees and costs.” Id.
Petitioner filed a response to the Secretary’s motion for review on February 15, 2018.
ECF No. 151. In it, Petitioner claims that the government’s argument that the Special Master
failed to perform a review of his fee petition is not supported by the record.2
DISCUSSION
I. Jurisdiction and Standard of Review
Congress established the National Vaccine Injury Compensation Program in 1986 to
provide a no-fault system to compensate persons who suffer vaccine-related injuries and deaths.
Figueroa v. Sec’y of HHS, 715 F.3d 1314, 1316–17 (Fed. Cir. 2013). A petition seeking
compensation under the Vaccine Act is filed in the Court of Federal Claims, after which the
Clerk of Court forwards it to the chief special master for assignment to a special master. 42
U.S.C. § 300aa-11(a)(1). The special master to whom the petition is assigned “issue[s] a decision
on such petition with respect to whether compensation is to be provided under the [Vaccine Act]
Program and the amount of such compensation.” Id. § 300aa-12(d)(3)(A). The Vaccine Act
further provides that “the special master . . . may award an amount of compensation to cover
2 The Court concludes that oral argument is unnecessary in this case.
3

Case 1:12-vv-00378-EDK Document 159 Filed 03/23/18 Page 4 of 9
petitioner’s reasonable attorneys’ fees and other costs . . . if the special master . . . determines
that the petition was brought in good faith and there was a reasonable basis for the claim for
which the petition was brought.” Id. § 300aa-15(e)(1). This grant of statutory authority includes
the authority to award interim attorneys’ fees prior to any decision on the merits. See id.; Avera
ex rel. Avera v. Sec’y of HHS, 515 F.3d 1343, 1352 (Fed. Cir. 2008); see also Shaw v. Sec’y of
HHS, 609 F.3d 1372, 1375 (Fed. Cir. 2010).
If a party files a motion for review of a decision of a special master, the Vaccine Act
grants the Court of Federal Claims jurisdiction to review the record of the proceedings before the
special master and authority, upon such review, to:
(A) [U]phold the findings of fact and conclusions of law of the
special master and sustain the special master’s decision,
(B) [S]et aside any findings of fact or conclusion of law of the
special master found to be arbitrary, capricious, an abuse of
discretion, or otherwise not in accordance with law and issue its
own findings of fact and conclusions of law, or
(C) [R]emand the petition to the special master for further action in
accordance with the court’s direction.
42 U.S.C. § 300aa-12(e)(2); see also Vaccine Rule 27. This jurisdiction includes the power to
review a special master’s decision on interim attorneys’ fees and costs. Shaw, 609 F.3d at 1376.
The court “review[s] a decision of the special master . . . [to] determine if it is ‘arbitrary,
capricious, an abuse of discretion, or otherwise not in accordance with law.’” Avera, 515 F.3d at
1347 (quoting 42 U.S.C. § 300aa-12(e)(2)(B)). “In Vaccine Act cases . . . contesting a special
master’s determination of reasonable attorney’s fees, the applicable standard of review is abuse
of discretion.” Scharfenberger v. Sec’y of HHS, 124 Fed. Cl. 225, 231 (2015) (citing Hall v.
Sec’y of HHS, 640 F.3d 1351, 1356 (Fed. Cir. 2011)), appeal dismissed, No. 16-1467 (Fed. Cir.
Feb. 9, 2016).
II. The Merits
The Federal Circuit has “endorsed the use of the lodestar approach to determine what
constitutes ‘reasonable attorneys’ fees’ under the Vaccine Act.” Avera, 515 F.3d at 1347 (citing
Saxton ex rel. Saxton v. Sec’y of HHS, 3 F.3d 1517, 1521 (Fed. Cir. 1993)). Under that
approach, the special master or the court “first determines an initial estimate of a reasonable
attorneys’ fee by ‘multiplying the number of hours reasonably expended on the litigation times a
reasonable hourly rate.’” Id. at 1347–48 (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984));
see also Hall, 640 F.3d at 1353. The fee applicant bears the burden of proving that the number of
hours submitted for payment is reasonable; further, hours that are “excessive, redundant, or
otherwise unnecessary” will not be compensated. See Hensley v. Eckerhart, 461 U.S. 424, 434,
437 (1983). A reasonable rate is ‘“the prevailing market rate,’ defined as the rate ‘prevailing in
the community for similar services by lawyers of reasonably comparable skill, experience, and
reputation.’” Avera, 515 F.3d at 1348 (quoting Blum, 465 U.S. at 896 n.11). The fee applicant
4

Case 1:12-vv-00378-EDK Document 159 Filed 03/23/18 Page 5 of 9
bears the burden of establishing the reasonableness of the rate at which he seeks compensation as
well. Hensley, 461 U.S. at 437; Guy v. Sec’y of HHS, 38 Fed. Cl. 403, 405 (1997).
In this case, the special master did not follow these principles. He issued an award of fees
and costs without determining whether the hours claimed were reasonable and without finding
that the requested hourly rate reflected the prevailing market rate in the relevant community.
Doing so appears to be patently at odds with the explicit language of the Vaccine Act, which
provides that “the special master . . . may award an amount of compensation to cover petitioner’s
reasonable attorneys’ fees and other costs.” 42 U.S.C. § 300aa-15(e)(1) (emphasis added). The
statute thus cabins the special master’s statutory authority to award compensation for attorneys’
fees by requiring that the fees and costs awarded be reasonable. And the controlling precedent
requires the special master to independently determine reasonableness by applying the lodestar
method described above. See, e.g., Sabella v. Sec’y of HHS, 86 Fed. Cl. 201, 208–09 (2009).
Nonetheless, in this case the special master did not use the lodestar approach; in fact he
made no independent reasonableness determination at all. Instead, he applied the “waiver” theory
that he first articulated in Swintosky, which posits that if the government fails to lodge objections
to the reasonableness of the fees and costs requested, then it is appropriate to grant the request in
full without conducting any independent review.
Swintosky’s reasoning, however, was deeply flawed. In Swintosky, as in the present case,
the Secretary declined to take a position regarding the reasonableness of the petitioner’s fee
request in its response to the petitioner’s fee application. 2017 WL 5899239, at *2. Instead, as in
this case, he recommended that the special master exercise his “discretion [to] determine a
reasonable award.” Id. (quotation omitted).
The special master did not take kindly to the Secretary’s pronouncement of deference to
the special master’s discretion and the Secretary’s statement of intent not to engage with the
specifics of the fee application. Rather, he opined that the Secretary’s failure to provide views
regarding the reasonableness of the fee request was inconsistent with the Secretary’s obligation
to “participate” in “all proceedings brought by the filing of a petition.” Id. (quoting 42 U.S.C.
§ 300aa-12(b)(1)). In addition, he stated that the Secretary had put him in what he characterized
as “an awkward situation” that would require him to act in the role of a “fees and costs
inquisitor.” Id. at *2–3 (quotation omitted). The special master appeared to agree with the
petitioner that—because he was under no obligation to seek clarification from the petitioner—the
petitioner might be unfairly deprived of an opportunity to address any “issues or misperceptions
regarding fees or costs” that the special master might harbor. See id. at *3 (quotation omitted).
The Court finds the special master’s “fairness” concerns misplaced. Here, Mr.
Dominguez had every opportunity (and an obligation) to make his case when he filed his fee
application. See Hensley, 461 U.S. at 437 (stating that “the fee applicant bears the burden of
establishing entitlement to an award and documenting the appropriate hours expended and hourly
rates”). He is not entitled to a second opportunity (presumably in a reply to the Secretary’s
objections) that might allow him to address “misapprehensions” or issues that the special master
may harbor about his request.
5

Case 1:12-vv-00378-EDK Document 159 Filed 03/23/18 Page 6 of 9
To the contrary, it is well-established that—notwithstanding similar “fairness”
concerns—a special master may adjust an attorney fee award downward sua sponte, even if the
opposing party has not lodged an objection in support of the reduction. See Sabella, 86 Fed. Cl.
at 208–09 (rejecting argument that sua sponte reduction in fees deprives the fee applicant of
ability to offer evidence in support of the reasonableness of her request); see also
Scharfenberger, 124 Fed. Cl. at 234 (noting that “petitioner bears the burden of proof, and
respondent in fact is not required to make any objection for the special master to deny fees and
costs” (quotation omitted)); Savin ex rel. Savin v. Sec’y of HHS, 85 Fed. Cl. 313, 318 (2008)
(even absent objection by the government, a special master may sua sponte reduce a fee request
where he or she possesses factual or experiential foundation upon which to do so, for “[t]he
Vaccine Act compels each special master to determine independently whether a particular
request is reasonable,” and “[t]his obligation is not suspended—nor the sound discretion and
common sense that underlie it rendered inoperable—merely because respondent fail[s] to object
to a particular fee item”); Duncan ex rel. Duncan v. Sec’y of HHS, No. 99-455V, 2008 WL
4743493, at *1 (Fed. Cl. Aug. 4, 2008) (affirming special master’s sua sponte reduction of an
attorney fee request and observing that “the Special Master has an independent responsibility to
satisfy himself that the fee award is appropriate and [is] not limited to endorsing or rejecting
respondent’s critique”); Guy, 38 Fed. Cl. at 406 (“[I]n determining the attorneys’ fees[,] the
special master is not limited to the objections raised by respondent.” (citing Moorhead v. United
States, 18 Cl. Ct. 849, 854 (1989))); Estate of Rosas v. Sec’y of HHS, No. 12-754V, 2018 WL
578940, at *4 n.8 (Fed. Cl. Office of the Special Masters Jan. 5, 2018) (rejecting petitioner’s
argument that special master should award full amount of fees requested without further analysis
because of respondent’s failure to object because Vaccine Act “compels each special master to
determine independently whether a particular request is reasonable” (quotation omitted)); Guffey
ex rel. Warfle v. Sec’y of HHS, No. 05-1399V, 2012 WL 4845635, at *13 (Fed. Cl. Office of the
Special Masters Sept. 21, 2012) (“A special master may reduce a request for fees and costs that
is not reasonable sua sponte, without regard for whether the respondent objected to a particular
request.” (citation omitted)).
Further, the Court notes that this obligation of independent review is not unique to the
Vaccine Act’s attorney fee provisions. It has been imposed on adjudicators under a variety of
fee-shifting statutes. See Broyles v. Dir., Office of Workers’ Comp. Programs, 974 F.2d 508, 510
(4th Cir. 1992) (holding that under the Equal Access to Justice Act, “although the [government]
ha[d] not challenged the number of hours claimed, [the court had] the responsibility of
determining whether the fees sought [we]re reasonable,” which “requires an examination of
whether the hours claimed are reasonable when viewed in the light of the question presented, the
state of the law, and the experience and expertise of the attorneys” (emphasis in original)); see
also Pa. Envtl. Def. Found. v. Canon-McMillan Sch. Dist., 152 F.3d 228, 232–34 (3d Cir. 1998)
(reversing district court’s use of process akin to “silent auction” to determine attorney fee award
under 42 U.S.C. § 1988; although neither party objected to the procedure, the district court was
obligated to make reasonableness determination on the basis of controlling lodestar principles);
Am. Petroleum Inst. v. EPA, 72 F.3d 907, 912, 915 (D.C. Cir. 1996) (noting that, in assessing
whether a requested attorneys’ fee was reasonable under 42 U.S.C. § 7607(f), the court was
“duty bound to recall that Congress required [it] to exercise [its] independent judgment on the
reasonableness of fees requested before taxing them against the United States”; that “petitioners
bear the burden of demonstrating the reasonableness of each element of their fee request”; and
that “the court has a duty to independently assess the reasonableness of fees sought from the
6

Case 1:12-vv-00378-EDK Document 159 Filed 03/23/18 Page 7 of 9
government” (quotation omitted)); Jordan v. Mark IV Hair Styles, Inc., 806 F.2d 695, 697–98
(6th Cir. 1986) (in awarding attorneys’ fees in a class action under 42 U.S.C. § 1988, the court
was required to evaluate the reasonableness of the fees requested whether or not defendant
responded to the petition); Wojtkowski v. Cade, 725 F.2d 127, 130 (1st Cir. 1984) (finding that
“court was not obligated . . . to adopt the rate and hours claimed by [the plaintiff’s] attorney[]
merely because the defendants failed to oppose his fee request or challenge his attorney’s
affidavit,” and observing that 42 U.S.C. § 1988 (under which the court “in its discretion, may
allow the prevailing party . . . a reasonable attorney’s fee as part of the costs”) “confer[s] both
responsibility and authority upon the court to control the reasonableness of the fee”).3
Finally, the Court agrees with the Secretary that there is no support either in the Vaccine
Act or the Vaccine Rules for the special master’s conclusion that he may be relieved of his
responsibility to determine the reasonableness of Petitioner’s fee application by the
government’s failure to assert specific objections. To the contrary, Vaccine Rule 13 (governing
petitions for attorneys’ fees) provides that once an attorney fee application is filed, “the clerk will
forward the fee request to the special master for a decision thereon.” It imposes no obligation on
the Secretary to respond.
The special master was nonetheless of the view, expressed in Swintosky, that “a fee
application, as a motion, is also governed by Vaccine Rule 20, which lays out general procedures
and establishes deadlines for responses to motions.” Swintosky, 2017 WL 5899239, at *4.
Accordingly, he observed, “the silence in § 300aa–15(e) or in Vaccine Rule 13 on the
Secretary’s role does not excuse the Secretary from meeting an obligation to present meaningful
arguments.” Id.
Rule 20, however, does not cross-reference Rule 13 or indicate in any way that it is
applicable to fee petitions. Further, even if Rule 20 were somehow read to impose a requirement
that the Secretary lodge specific objections to attorney fee applications, Rule 20 does not provide
that a failure to respond will result in a default ruling as to an application for an award of
attorneys’ fees. And as at least one court has held, the violation of such a procedural rule cannot
serve as sufficient justification for the issuance of an award of fees and costs without
determining their reasonableness, because such a determination is statutorily mandated. See
3 The special master’s “waiver” theory also finds no support in decisions describing the burden
of rebuttal that is placed on a party opposing a fee application. Thus, in Swintosky, the special
master referenced—among other things—the court’s holding in National Association of
Concerned Veterans v. Secretary of Defense, 675 F.2d 1319, 1326 (D.C. Cir. 1982), that “[o]nce
the fee applicant has provided support for the requested rate, the burden falls on the Government
to go forward with evidence that the rate is erroneous.” Swintosky, 2017 WL 5899239, at *3
(quoting Nat’l Assoc. of Concerned Veterans, 675 F.2d at 1326). But that decision addressed the
allocation of burdens of proof when determining whether a fee request is reasonable. It is
inapposite here because in this case (as in Swintosky) the special master decided not to make any
reasonableness determination at all. As a result, he did not decide whether the fee applicant had
made a prima facie case in support of the requested hours and rate, which are the findings
necessary to impose any burden of rebuttal on the government.
7

Case 1:12-vv-00378-EDK Document 159 Filed 03/23/18 Page 8 of 9
Jordan, 806 F.2d at 697–98 (reversing an award of fees that had been based on the opposing
party’s procedural default under local rules of court, and holding that notwithstanding the rule,
the district court had an obligation to independently review the reasonableness of the fee award
requested by class counsel).4
In closing, the Court notes that it is not unsympathetic to the toll that attorneys’ fees
litigation takes on the time of the special masters and on the Vaccine Program, particularly given
the right of vaccine petitioners to file multiple requests for awards of interim attorneys’ fees
while their cases are pending. Even when the opposing party assists a tribunal by drawing
attention to potential defects in a fee application, the adjudication of fee requests is often tedious
and time consuming. The time a special master spends poring over fee applications is time that
he or she cannot spend deciding requests for compensation by injured petitioners. It would be in
all parties’ interests (and in the interest of the Vaccine Program itself) if fee requests could be
resolved by settlement and without the special masters’ intervention. But these considerations,
while compelling, obviously cannot serve as justifications for dispensing with the statutory
requirement that special masters review and make determinations regarding the reasonableness
of fee applications.
In this case, the special master abused his discretion by awarding Petitioner attorneys’
fees and costs without determining whether the fees and costs awarded were reasonable.
Therefore, his decision must be set aside and the matter remanded to allow him to reconsider
Petitioner’s application for fees and to apply the lodestar approach set forth in the controlling
precedent.
CONCLUSION
For the foregoing reasons, the government’s motion for review is GRANTED and the
special master’s decision on interim attorneys’ fees (ECF No. 138) is set aside as an abuse of
discretion. The case is REMANDED back to the special master for further proceedings
consistent with this opinion.
4 Of course, the Secretary’s failure to object to any part of the fee application is not without
consequence under the Vaccine Rules. To the contrary, it results in a waiver of the Secretary’s
right to press any such objections on appeal of the attorney fee award. See Vaccine Rule 8(f)(1)
(“Any fact or argument not raised specifically in the record before the special master will be
considered waived and cannot be raised by either party in proceedings on review of a special
master’s decision.”); Weddel v. Sec’y of HHS, 23 F.3d 388, 390 n.2 (Fed. Cir. 1994) (noting that
Vaccine Rule 8(f) “expressly forbid[s]” the court from considering arguments not raised before
the special master); McMillan ex rel. McMillan v. Sec’y of HHS, 26 Cl. Ct. 357, 358 (1992)
(where government failed to raise any objections to fee petition before special master and special
master found the fee request reasonable and awarded the same, government waived its right to
raise specific objections to that award in a motion for review, based on Vaccine Rule 8(f) and on
the general rule of waiver resulting from a party’s failure to object). Apparently, the Secretary
has determined that waiver of the right to challenge specific aspects of a special master’s fee
determination is an acceptable price to pay for the time saved in responding to fee applications.
8

Case 1:12-vv-00378-EDK Document 159 Filed 03/23/18 Page 9 of 9
IT IS SO ORDERED.
s/ Elaine D. Kaplan
ELAINE D. KAPLAN
Judge
9

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_12-vv-00378-3
Date issued/filed: 2018-05-02
Pages: 4
Docket text: PUBLIC DECISION (Originally filed: 4/2/2018) regarding 161 DECISION of Special Master. Signed by Special Master Christian J. Moran. (abs) Service on parties made.
--------------------------------------------------------------------------------
Case 1:12-vv-00378-EDK Document 166 Filed 05/02/18 Page 1 of 4
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
* * * * * * * * * * * * * * * * * * * * *
GEORGE DOMINGUEZ, *
* No. 12-378V
Petitioner, * Special Master Christian Moran
*
v. * Filed: April 2, 2018
*
SECRETARY OF THE HEALTH *
DEPARTMENT OF HEALTH AND * Motion for decision; tetanus,
HUMAN SERVICES, * diphtheria, acellular pertussis
* (“TDaP”) vaccine; Wegener’s
Respondent. * granulomatosis
* * * * * * * * * * * * * * * * * * * * *
Clifford J. Shoemaker, Shoemaker, Gentry & Knickelbein, Vienna, VA, for
petitioner;
Darryl R. Wishard, United States Dep’t of Justice, Washington, DC, for
respondent.
UNPUBLISHED DECISION DENYING COMPENSATION1
George Dominguez filed a petition under the National Childhood Vaccine
Injury Act, 42 U.S.C. § 300aa—10 through -34 on June 14, 2012. The petition
alleged that Mr. Dominguez developed Wegener’s granulomatosis or, in the
alternative, the condition was significantly aggravated after he received the tetanus,
diphtheria, acellular pertussis (“TDaP”) vaccine on August 31, 2011. Petition,
filed June 14, 2012, at 1. The information in the record, however, does not show
entitlement to an award under the Program.
1 The E-Government Act, 44 § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services), requires that the Court post this decision on its website.
Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing redaction of
medical information or other information described in 42 U.S.C. § 300aa-12(d)(4). Any
redactions ordered by the special master will appear in the document posted on the website.

Case 1:12-vv-00378-EDK Document 166 Filed 05/02/18 Page 2 of 4
I. Procedural History
On June 14, 2012, Mr. Dominguez filed a petition seeking compensation for
injuries he sustained following the administration of the TDaP vaccine on August
31, 2011. The petition alleges that the vaccine caused Mr. Dominguez to suffer
from and/or significantly aggravated Wegener’s granulomatosis.
On May 10, 2013, respondent filed his Rule 4 report concluding that
compensation was not appropriate in this case. Respondent points to the lack of a
medical theory connecting the TDaP vaccine and Wegener’s granulomatosis and
also the absence of any treating physicians making this connection.
On April 25, 2014, Mr. Dominguez’s initial counsel first provided notice of
her intent to withdraw. Her counsel’s eventual motion to withdraw was granted on
January 6, 2015.
On March 25, 2015, an order to show cause was issued. On April 29, 2015,
Mr. Dominguez’s current counsel entered his appearance and soon thereafter
settlement discussions recommenced.
On May 18, 2016, Mr. Dominguez filed a co-authored first expert report
from Judy A. Mikovits, Ph.D., and Francis W. Ruscetti, Ph.D. Exhibit 24.
Respondent then filed his first expert report from Dr. Thomas Forsthuber. Exhibit
H.
On August 8, 2016, a status conference was held to discuss the initial expert
reports. Mr. Dominguez was ordered to file a responsive expert report.
On January 6, 2017, Mr. Dominguez filed a second co-authored expert
report. Exhibit 68. On February 13, 2017, Mr. Dominguez advised that
respondent did not wish to continue settlement discussions and an entitlement
hearing was scheduled shortly after.
On March 8, 2017, respondent filed his second expert report from Dr.
Forsthuber. Exhibit OO.
An order for pre-hearing briefs was issued on September 8, 2017. Mr.
Dominguez filed his pre-hearing brief on December 22, 2017, and respondent filed
his brief on February 2, 2018.
2

Case 1:12-vv-00378-EDK Document 166 Filed 05/02/18 Page 3 of 4
At a status conference on March 20, 2018, the undersigned advised the
parties of his review of the case thus far. The undersigned identified weak aspects
of Mr. Dominguez’s case, the disparity in credentials between the parties’ experts,
and the tenuous nature of reasonable basis going forward. Order, issued Mar. 22,
2018, at 1-2.
On March 30, 2018, Mr. Dominguez moved for a decision dismissing his
petition. He stated that he is unable to prove that he is entitled to compensation in
the Vaccine Program. He acknowledges that a dismissal of his petition at this
stage will result in a judgment against him and will end all of his rights in the
Vaccine Program.
II. Analysis
To receive compensation under the National Vaccine Injury Compensation
Program, petitioners must prove either 1) that the vaccinee suffered a “Table
Injury” – i.e., an injury falling within the Vaccine Injury Table – corresponding to
one of the vaccinee’s vaccinations, or 2) that the vaccinee suffered an injury that
was actually caused by a vaccine. See §§ 300aa—13(a)(1)(A) and 300aa—
11(c)(1). An examination of the record did not uncover any evidence that Mr.
Dominguez suffered a “Table Injury.” Further, the record does not contain other
persuasive evidence indicating that Mr. Dominguez’s injuries are vaccine-caused.
Under the Act, a petitioner may not be given a Program award based solely
on the petitioner’s claims alone. Rather, the petition must be supported by either
medical records or by the opinion of a competent physician. § 300aa—13(a)(1).
In this case, because the medical records do not support Mr. Dominguez’s claim, a
medical opinion must be offered in support. Though a medical opinion has been
offered, it is not persuasive.
Drs. Mikovits and Ruscetti theorize than a vaccine can trigger a cytokine and
chemokine storm, but do not explain how the storm could cause Wegener’s
granulomatosis in particular. Exhibit 24 at 10. For respondent, Dr. Forsthuber
contends that the articles cited by Drs. Mikovits and Ruscetti do not support their
theory and that the causes of Wegner’s granulomatosis are unknown. Exhibit H at
6-8. Drs. Mikovits and Ruscetti proposed a vague timing for the onset of
symptoms of a few days to months. Exhibit 24 at 13. Based on the undersigned’s
previous experience, cytokine-based theories have a quick onset of perhaps two
days. As for the experts’ credentials, only Dr. Forsthuber is a medical doctor and,
thus, is most qualified to interpret Mr. Dominguez’s medical records. Lastly,
3

Case 1:12-vv-00378-EDK Document 166 Filed 05/02/18 Page 4 of 4
based on a limited number of court appearances, the undersigned has found Dr.
Forsthuber to be more credible than Drs. Mikovits and Ruscetti.
Accordingly, the undersigned finds that petitioner has failed to demonstrate
that Mr. Dominguez suffered a “Table Injury,” that the TDaP vaccination “actually
caused” Mr. Dominguez’s Wegener’s granulomatosis, or that the TDaP
vaccination “significantly aggravated” his Wegener’s granulomatosis.
Thus, this case is dismissed for insufficient proof. The Clerk shall enter
judgment accordingly.
Any questions may be directed to my law clerk, Andrew Schick, at (202)
357-6360.
IT IS SO ORDERED.
s/Christian J. Moran
Christian J. Moran
Special Master
4